Paul Friedman

Paul Friedman

Chairman at PRELUDE THERAPEUTICS INCORPORATED

Net worth: 255 M $ as of 2024-03-30

81 year
Health Technology
Consumer Services
Commercial Services

Profile

Paul A. Friedman is a businessperson who has been at the helm of 5 different companies and currently occupies the position of Chairman for Prelude Therapeutics, Inc. and Chairman, President & Chief Executive Officer at Madrigal Pharmaceuticals, Inc. Paul A. Friedman is also on the board of Incyte Corp. (former President, Chief Executive Officer & Director), Alexion Pharmaceuticals, Inc. and Gliknik, Inc. and Member of American Society for Clinical Investigation, Member of American Society for Biochemistry & Molecular Biology, Inc. and Member of American Society for Pharmacology & Experimental Therapeutic. Paul A. Friedman previously occupied the position of Director at Cerulean Pharma, Inc., President for DuPont Pharmaceuticals Research Laboratories, President-Research & Development at DuPont Merck Pharmaceutical Co., Senior Vice President of Merck Research Laboratories Massachusetts LLC and Associate Professor-Medicine & Pharmacology at Harvard Medical School. Dr. Friedman received an undergraduate degree from Princeton University and a doctorate from Harvard Medical School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-04-07 944,226 ( 4.75% ) 252 M $ 2024-03-30
2023-06-15 510,474 ( 0.93% ) 2 M $ 2024-03-30

Paul Friedman active positions

CompaniesPositionStart
MADRIGAL PHARMACEUTICALS, INC. Director/Board Member 2023-06-14
PRELUDE THERAPEUTICS INCORPORATED Chairman -
Corporate Officer/Principal 2009-05-28
American Society for Pharmacology & Experimental Therapeutic Corporate Officer/Principal 2009-05-28
Corporate Officer/Principal -
All active positions of Paul Friedman

Former positions of Paul Friedman

CompaniesPositionEnd
ALEXION PHARMACEUTICALS, INC. Director/Board Member 2021-07-13
INCYTE CORPORATION Chief Executive Officer 2014-11-12
VERASTEM, INC. Director/Board Member 2017-04-26
Chairman 2016-06-29
░░░░░ ░░░░░░░░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Paul Friedman's experience

Training of Paul Friedman

Princeton University Undergraduate Degree
Harvard Medical School Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Paul Friedman's experience

Connections

100 +

1st degree connections

21

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies4
INCYTE CORPORATION

Health Technology

VERASTEM, INC.

Health Technology

PRELUDE THERAPEUTICS INCORPORATED

Health Technology

MADRIGAL PHARMACEUTICALS, INC.

Health Technology

Private companies15

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

American Society for Pharmacology & Experimental Therapeutic

DuPont Pharmaceuticals Research Laboratories

Health Technology

See company connections